Novartis Ag

Rediff.com » News » Novartis Ag

News for Novartis Ag

Business

US sues Novartis, alleging kickbacks to pharmacies

Novartis disputes the claims and will defend itself, spokeswoman Julie Masow said in an email.The US government filed a civil fraud lawsuit against Novartis AG on Tuesday, accusing a unit of the......

'Novartis case: SC ruling wise and balanced'

The Supreme Court recently rejected the plea of Novartis AG for patent protection of its anti-cancer drug Glivec.The Supreme Court judgement (pages 22 -26) quite extensively quoted from Sudip......

SC decision on Novartis "historic": Anand Sharma

Commerce and Industry Minister Anand Sharma on Monday described the Supreme Court judgement rejecting Novartis AG plea for its cancer drug as "historic" and said Indian Patent Law conforms fully......

SC denies patent to Novartis's cancer drug Glivec

Swiss pharma major Novartis AG on Monday lost a seven-year long legal battle for getting its blood cancer drug Glivec patented in India and to restrain Indian companies from manufacturing generic......

Natco, Cipla up after SC dismisses Novartis plea

Shares in Natco Pharma and Cipla gain after the Supreme Court on Monday dismissed Swiss drugmaker Novartis AG's petition seeking patent for its cancer drug Glivec.In a landmark judgment that has......

Web results for Novartis Ag

European Drug Delivery Technology Market Worth $59.1 Billion by 2017

The Report "European Drug Delivery TechnologyMarket(Metered Dose Inhalers, Needle-free Injectors, Auto-injectors, Nasal Sprays, Transdermal... ...

http://in.advfn.com/p.php?pid=nmona&article=58059207

Three Scientists to Receive Prestigious Novartis Prizes for Immunology at 15th International Congress of Immunology

Novartis International AG / . Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this... ...

http://www.andhranews.net/Business/2013/Three-Scientists-Receive-Prestigious-Novartis-Prizes-25932.htm

Novartis phase III study shows Jakavi improves overall survival of myelofibrosis patients and impacted an underlying mechanism of disease

Novartis announced results from a phase III three-year follow-up study that showed Jakavi (ruxolitinib) demonstrated improved overall survival and... ...

http://www.pharmabiz.com/NewsDetails.aspx?aid=75991&sid=2

Japanese Pharmaceutical Company Eisai Expands UK Site with New Facility

Eisai CO. Ltd (Frankfurt) (EII) Quote : 28.893 0.52 (1.83%) @ 10:49PM Eisai CO. Ltd (Frankfurt) (FWB:EII) Intraday Stock Chart Today :... ...

http://in.advfn.com/p.php?pid=nmona&article=58013714

Analysis of the North American Oral Solid Drug Dosage Excipients Market

/PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: ... ...

http://in.advfn.com/p.php?pid=nmona&article=57966320

See All

Rediff News

Novartis Ag

News for Novartis Ag

US sues Novartis, alleging kickbacks to pharmacies

'Novartis case: SC ruling wise and balanced'

SC decision on Novartis "historic": Anand Sharma

SC denies patent to Novartis's cancer drug Glivec

Natco, Cipla up after SC dismisses Novartis plea

Related Tags

Top Coverage News

Indian Premier League - IPL 2013

Coverage: The Match-Fixing Episode II - spot-fixing trial

Sachin Tendulkar : Cup of praise overfloweth - Reactions

Complete coverage of Mumbai blasts

Decoding India’s Corruption Wars - Ajit Balakrishnan's Blog